Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

ADLYXIN

×

Overview

What is ADLYXIN?

ADLYXIN contains lixisenatide, which acts as a GLP-1 receptor agonist. Lixisenatide is a peptide containing 44 amino acids, which is amidated at the C-terminal amino acid (position 44). The order of the amino acids is given in the figure below. Its molecular weight is 4858.5 and its molecular formula is CHNOS. Lixisenatide has the following chemical structure:

ADLYXIN injection is a sterile, clear, colorless aqueous solution for subcutaneous administration. ADLYXIN is supplied in two single-patient use prefilled pens. Each green prefilled pen contains 3 mL solution and each mL contains 50 mcg lixisenatide. Each burgundy prefilled pen contains 3 mL solution, and each mL contains 100 mcg lixisenatide. Inactive ingredients for both prefilled pens are glycerol 85% (54 mg), sodium acetate trihydrate (10.5 mg), methionine (9.0 mg), metacresol (8.1 mg), and water for injection. Hydrochloric acid and/or sodium hydroxide may be added to adjust pH.



What does ADLYXIN look like?



What are the available doses of ADLYXIN?

ADLYXIN is a clear solution for subcutaneous injection available as:

What should I talk to my health care provider before I take ADLYXIN?

Pregnancy: ADLYXIN should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus ().

How should I use ADLYXIN?

ADLYXIN is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Initiate at 10 mcg once daily for 14 days. On Day 15, increase dosage to 20 mcg once daily ().

Administer once daily within one hour before the first meal of the day ().

Inject subcutaneously in the abdomen, thigh or upper arm ().


What interacts with ADLYXIN?

Sorry No Records found


What are the warnings of ADLYXIN?

Sorry No Records found


What are the precautions of ADLYXIN?

Sorry No Records found


What are the side effects of ADLYXIN?

Sorry No records found


What should I look out for while using ADLYXIN?

ADLYXIN is contraindicated in patients with known hypersensitivity to lixisenatide or to any component of ADLYXIN. Hypersensitivity reactions including anaphylaxis have occurred with ADLYXIN


What might happen if I take too much ADLYXIN?

During clinical studies, doses up to 30 mcg of lixisenatide twice daily (3 times the daily recommended dose) were administered to type 2 diabetic patients in a 13-week study. The 30 mcg dose of lixisenatide is not an approved dose. An increased incidence of gastrointestinal disorders was observed.

In case of overdose, appropriate supportive treatment should be initiated according to the patient's clinical signs and symptoms.


How should I store and handle ADLYXIN?

Prior to first use, ADLYXIN should be stored in a refrigerator, 36°–46°F (2°C–8°C). Do not freeze. Keep the prefilled pen in the original package to protect it from light.After first use, store below 86°F (30°C). Replace the pen cap after each use to protect from light. Discard pen 14 days after first use.Prior to first use, ADLYXIN should be stored in a refrigerator, 36°–46°F (2°C–8°C). Do not freeze. Keep the prefilled pen in the original package to protect it from light.After first use, store below 86°F (30°C). Replace the pen cap after each use to protect from light. Discard pen 14 days after first use.Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture. Rosuvastatin calcium tablets are available containing 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin.5 mg: Yellow, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "5" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4502-3)Bottles of 90 (NDC 60505-4502-9)Unit dose blisters of 100 (NDC 60505-4502-0)10 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "10" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4503-3)Bottles of 90 (NDC 60505-4503-9)Unit dose blisters of 100 (NDC 60505-4503-0)20 mg: Pink, round, biconvex film-coated tablets. Engraved "APO" on one side, "ROS" over "20" on the other side.They are supplied as follows:Bottles of 30 (NDC 60505-4504-3)Bottles of 90 (NDC 60505-4504-9)Unit dose blisters of 100 (NDC 60505-4504-0)40 mg: Pink, oval, biconvex film-coated tablets. Engraved "APO" on one side, "ROS40" on the other side. They are supplied as follows:Bottles of 30 (NDC 60505-4505-3)Bottles of 90 (NDC 60505-4505-9)Unit dose blisters of 100 (NDC 60505-4505-0)StorageStore at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. Protect from moisture.


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Lixisenatide is a GLP-1 receptor agonist. Lixisenatide increases glucose-dependent insulin release, decreases glucagon secretion, and slows gastric emptying.

Non-Clinical Toxicology
ADLYXIN is contraindicated in patients with known hypersensitivity to lixisenatide or to any component of ADLYXIN. Hypersensitivity reactions including anaphylaxis have occurred with ADLYXIN





With potassium supplements and potassium-sparing diuretics:

With lithium:

With antacids:

Gold:

Non-steroidal anti-inflammatory agents including selective cyclooxygenase-2 inhibitors (COX-2 inhibitors):

The antihypertensive effect of ACE inhibitors, including fosinopril may be attenuated by NSAIDs.

Agents that inhibit mTOR:

  Dual Blockade of the Renin-Angiotensin System (RAS):

Do not co-administer aliskiren with fosinopril in patients with diabetes. Avoid use of aliskiren with fosinopril in patients with renal impairment (GFR <60 ml/min).

Other:

In a pharmacokinetic interaction study with warfarin, bioavailability parameters, the degree of protein binding, and the anticoagulant effect (measured by prothrombin time) of warfarin were not significantly changed.

In clinical trials of ADLYXIN, there have been cases of anaphylaxis determined to be related to ADLYXIN (frequency of 0.1% or 10 cases per 10,000 patient-years). Other serious hypersensitivity reactions including angioedema also occurred

Inform and closely monitor patients with a history of anaphylaxis or angioedema with another GLP-1 receptor agonist for allergic reactions, because it is unknown whether such patients will be predisposed to anaphylaxis with ADLYXIN. ADLYXIN is contraindicated in patients with known hypersensitivity to lixisenatide If a hypersensitivity reaction occurs, the patient should discontinue ADLYXIN and promptly seek medical attention.

The following serious reactions are described below or elsewhere in the prescribing information:

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).